Form 4: Inotiv Director David Landman Receives Stock Grant

Director David Landman reports receiving a grant of 39,392 shares of Inotiv, Inc. restricted stock.

Summary

• On March 14, 2025, David Landman, a director of Inotiv, Inc., acquired 39,392 shares of common stock through a grant.
• The restricted stock units vest in full on March 14, 2026, or immediately prior to the next annual meeting of stockholders if stepping down from the Board.
• Following the transaction, Landman directly owns 216,243 shares of Inotiv, Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The stock grant indicates confidence in the company's future, but it's a routine transaction.

Positives

• The grant of restricted stock units to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's long-term success.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance, but the stock grant suggests an ongoing commitment to incentivizing key personnel.

Industry Context

Stock grants are a common form of executive compensation in the biotech and pharmaceutical services industry, aligning management's interests with shareholder value.

Stakeholder Impact

• Shareholders may view the stock grant positively as it aligns the director's interests with the company's performance.

Key Dates